Cargando…

Conversion of left atrial volume to diameter for automated estimation of sudden cardiac death risk in hypertrophic cardiomyopathy

BACKGROUND: A subset of patients with hypertrophic cardiomyopathy (HCM) is at high risk of sudden cardiac death (SCD). Practice guidelines endorse use of a risk calculator, which requires entry of left atrial (LA) diameter. However, American Society of Echocardiography (ASE) guidelines recommend the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhopalwala, Huzefa, Dewaswala, Nakeya, Liu, Sijia, Scott, Christopher G., Welper, James M., Akinnusotu, Oluwatoyin, Bos, Johan Martijn, Ommen, Steve R., Ackerman, Michael J., Pellikka, Patricia A., Geske, Jeffrey B., Noseworthy, Peter, Arruda‐Olson, Adelaide M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986336/ https://www.ncbi.nlm.nih.gov/pubmed/33325582 http://dx.doi.org/10.1111/echo.14943

Ejemplares similares

Natural language processing of implantable cardioverter-defibrillator reports in hypertrophic cardiomyopathy: A paradigm for longitudinal device follow-up
por: Siontis, Konstantinos C., et al.
Publicado: (2021)

Natural language processing for identification of hypertrophic cardiomyopathy patients from cardiac magnetic resonance reports
por: Dewaswala, Nakeya, et al.
Publicado: (2022)

Deep Neural Network for Cardiac Magnetic Resonance Image Segmentation
por: Chen, David, et al.
Publicado: (2022)

Refractory Torsades de Pointes Due to Dofetilide Overdose
por: Crosby, James, et al.
Publicado: (2021)

Predictors of Mortality for Patients with COVID-19 in the Rural Appalachian Region
por: Bhopalwala, Huzefa, et al.
Publicado: (2022)

COVID-19 VERSUS IMMUNE CHECKPOINT INHIBITOR MYOCARDITIS: A CLINICAL DILEMMA
por: Dewaswala, Nakeya, et al.
Publicado: (2023)

Tandem deep learning and logistic regression models to optimize hypertrophic cardiomyopathy detection in routine clinical practice
por: Maanja, Maren, et al.
Publicado: (2022)

High Prevalence of Cardiac Amyloidosis in Clinically Significant Aortic Stenosis: A Meta-Analysis
por: Arshad, Samiullah, et al.
Publicado: (2022)

Clinical course of patients with hypertrophic cardiomyopathy away from tertiary referral care
por: Garmany, Ramin, et al.
Publicado: (2023)

IMPACT OF COVID-19 VACCINATION AFTER ORTHOTOPIC HEART TRANSPLANTATION
por: Noor, Ahmed, et al.
Publicado: (2022)

Utility of T-wave amplitude as a non-invasive risk marker of sudden cardiac death in hypertrophic cardiomyopathy
por: Sugrue, Alan, et al.
Publicado: (2017)

Outcomes of Heart Failure in COVID-19 Patients: An Appalachian Experience
por: Bhopalwala, Huzefa, et al.
Publicado: (2022)

Cardiac Troponin-I and COVID-19: A Prognostic Tool for In-Hospital Mortality
por: AL Abbasi, Baher, et al.
Publicado: (2020)

Sex, Survival, and Cardiomyopathy: Differences Between Men and Women With Hypertrophic Cardiomyopathy
por: Siontis, Konstantinos C., et al.
Publicado: (2019)

Ultrasound Enhancing Agents with Transthoracic Echocardiography for Maximal Wall Thickness in Hypertrophic Cardiomyopathy
por: Bois, John P., et al.
Publicado: (2023)

Does Thrombocytopenia Truly Correlate with COVID-19 Severity?
por: Hana, Caroline, et al.
Publicado: (2020)

Artificial Intelligence and Lung Cancer: Impact on Improving Patient Outcomes
por: Gandhi, Zainab, et al.
Publicado: (2023)

In-Hospital Outcomes of Acute Ischemic Stroke in Patients With Hypertrophic Cardiomyopathy
por: Sun, Daokun, et al.
Publicado: (2022)

Radiolucent Mechanical Valve: Chest Radiography Conundrum
por: Alabdaljabar, Mohamad S., et al.
Publicado: (2021)

Surgical management of diastolic heart failure after septal myectomy for obstructive hypertrophic cardiomyopathy
por: Sun, Daokun, et al.
Publicado: (2021)

Prevention of Sudden Death in Hypertrophic Cardiomyopathy
por: Arteaga-Fernández, Edmundo, et al.
Publicado: (2018)

Impact of Race and Ethnicity on Use and Outcomes of Septal Reduction Therapies for Obstructive Hypertrophic Cardiomyopathy
por: Patlolla, Sri Harsha, et al.
Publicado: (2022)

Prevention of sudden cardiac death in hypertrophic cardiomyopathy: Risk assessment using left atrial diameter predicted from left atrial volume
por: Mills, Helen, et al.
Publicado: (2020)

Proteomic and phosphoproteomic analyses of myectomy tissue reveals difference between sarcomeric and genotype-negative hypertrophic cardiomyopathy
por: Garmany, Ramin, et al.
Publicado: (2023)

Atrial Fibrillation in Hypertrophic Cardiomyopathy: Prevalence, Clinical Correlations, and Mortality in a Large High‐Risk Population
por: Siontis, Konstantinos C., et al.
Publicado: (2014)

Marked Up-Regulation of ACE2 in Hearts of Patients With Obstructive Hypertrophic Cardiomyopathy: Implications for SARS-CoV-2–Mediated COVID-19
por: Bos, J. Martijn, et al.
Publicado: (2020)

Association of Preoperative Sleep-Disordered Breathing With Functional Status After Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy
por: Sun, Daokun, et al.
Publicado: (2022)

Predictors of Exercise Capacity in Patients with Hypertrophic Obstructive Cardiomyopathy
por: Smith, Joshua R., et al.
Publicado: (2018)

Risk factors of sudden cardiac death in hypertrophic cardiomyopathy
por: Hong, Ying, et al.
Publicado: (2022)

Defying the Odds of Sudden Cardiac Death in Hypertrophic Cardiomyopathy
por: Rostomian, Ara H., et al.
Publicado: (2020)

Differing strategies for sudden death prevention in hypertrophic cardiomyopathy
por: Maron, Martin S, et al.
Publicado: (2023)

Left Ventricular Diameter and Risk Stratification for Sudden Cardiac Death
por: Narayanan, Kumar, et al.
Publicado: (2014)

COVID-19 Infection and Late Manifestation of Pulmonary Aspergillosis
por: Bhopalwala, Huzefa, et al.
Publicado: (2022)

Sociotechnical Intervention for Improved Delivery of Preventive Cardiovascular Care to Rural Communities: Participatory Design Approach
por: Partogi, Michelle, et al.
Publicado: (2022)

Hypertrophic cardiomyopathy: Sudden cardiac death risk stratification in adults
por: Jordà, Paloma, et al.
Publicado: (2018)

HIGH INCIDENCE OF SPONTANEOUS PNEUMOTHORAX IN CRITICALLY ILL PATIENTS WITH SARS-COV-2
por: Reddy, Renuka, et al.
Publicado: (2020)

Exuberant late gadolinium enhancement in hypertrophic cardiomyopathy as a precursor to ‘burn out’
por: Gweun, John, et al.
Publicado: (2022)

MYBPC3 mutations are associated with a reduced super-relaxed state in patients with hypertrophic cardiomyopathy
por: McNamara, James W., et al.
Publicado: (2017)

Electrocardiographic amplitudes: a new risk factor for sudden death in hypertrophic cardiomyopathy
por: Östman-Smith, Ingegerd, et al.
Publicado: (2010)

Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy: What has Changed in The Guidelines?
por: Reis, Liliana, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_adaug5o7o6b42757f43np5hpcp